Related Experiment Video
Updated: Dec 3, 2025

Online Explorative Study on the Learning Uses of Virtual Reality Among Early Adopters
Published on: November 22, 2019
Survey data for COVID-19 vaccine preference analysis in the United Arab Emirates
Riham Muqattash1, Ibrahim Niankara2, Rachidatou I Traoret3
1Department of Accounting, College of Business, Al Ain University, Abu Dhabi, UAE.
Abstract:
In response to the call for interdisciplinary research on the potential effects of the coronavirus pandemic [1], this article presents a novel data set on individuals' COVID-19 vaccine preferences in the United Arab Emirates (UAE). The menu of our stated preference survey questionnaire is framed based on the World Health Organization's (WHO) SAGE working group on immunization developed matrix of vaccine determinants [2], which was itself informed by a systematic review of peer reviewed and grey literature, and by the expertise of the working group. Our survey was designed in a bilingual (Arabic and English) format, using Google Forms platform and delivered to respondents aged 18 years and older using the snowball sampling method between July 4th and August 4th 2020, gathering a total of 1109 responses. Study participants were recruited across all seven emirates of the UAE (see Fig. 1). As presented in the conceptual framework (see Fig. 2), the data set comprises (i) respondents socio-economic and demographic information, (ii) respondents willingness to spend time, and money to get the Covid-19 vaccine, and (iii) the vaccine determinants identified by the WHO's SAGE working group on immunization.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
08:47Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Related Concept Videos
Surveys
Survey Safety
Data Collection by Survey
Vaccinations
Types of Surveys
Bioavailability Study Design: Healthy Subjects Versus Patients